Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-022-06640-1.pdf
Reference26 articles.
1. DeMichele A, Yee D, Berry DA et al (2015) The neoadjuvant model is still the future for drug development in breast cancer. Clin Cancer Res. 21(13):2911–2915. https://doi.org/10.1158/1078-0432.CCR-14-1760
2. Chen JH, Feig BA, Hsiang JB, Butler JA, Mehta RS, Bahri S, Nalcioglu O, Su MY (2009) Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg 249(3):448–454. https://doi.org/10.1097/SLA.0b013e31819a6e01
3. Chudgar AV, Conant EF, Weinstein SP, Keller BM, Synnestvedt M, Yamartino P, McDonald ES (2017) Assessment of disease extent on contrast-enhanced MRI in breast cancer detected at digital breast tomosynthesis versus digital mammography alone. Clin Radiol 72(7):573–579. https://doi.org/10.1016/j.crad.2017.02.013
4. Masuda N, Lee S-J, Ohtani S, Im Y-H, Lee E-S, Yokota I, Kuroi K, Im S-A, Park B-W, Kim S-B, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park K-H, Sasano H, Ohashi Y, Toi M (2017) Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 376(22):2147–2159. https://doi.org/10.1056/NEJMoa
5. Von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W et al (2019) Trastuzumab Emtansine for residual invasive HER-2 positive breast cancer. N Engl J Med. 380:617–628. https://doi.org/10.1056/NEJMoa1814017
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Denoising and segmentation in medical image analysis: A comprehensive review on machine learning and deep learning approaches;Multimedia Tools and Applications;2024-05-17
2. A Comprehensive Review on Breast Cancer Detection, Classification and Segmentation Using Deep Learning;Archives of Computational Methods in Engineering;2023-07-07
3. Pre-Operative MRI in HER-2 Receptor Positive and Her-2 Receptor Negative Breast Cancer: A Comparison;Advances in Breast Cancer Research;2023
4. Mammographic and Ultrasonographic Imaging Analysis for Neoadjuvant Chemotherapy Evaluation: Volume Reduction Indexes That Correlate With Pathological Complete Response;Cureus;2022-10-05
5. Exploring the Evolution of the Topics and Emerging Trends of MRI in Breast Cancer: A Bibliometric Analysis From 2000 to 2021;2022-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3